Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Veltassa® (patiromer) – Expanded indication, new strength
October 2, 2023 - The FDA approved Vifor Pharma’s Veltassa (patiromer), for the treatment of hyperkalemia in adults and pediatric patients ages 12 years and older.
